Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heavy-chain diseases.

J P Fermand1, J C Brouet

  • 1Department of Immuno-Hematology, Hôpital Saint-Louis, Paris, France. immuno-hem@chu-stlouis.fr

Hematology/Oncology Clinics of North America
|January 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy.

Journal of neurology·2017
Same author

Non-cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients.

Leukemia·2016
Same author

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma.

Leukemia·2013

This review highlights the varied abnormalities in heavy chain deposition (HCD) proteins and associated lymphoproliferative disorders. Despite diversity, HCD-producing cells may originate from a single B cell precursor undergoing gene mutation.

Area of Science:

  • Hematology
  • Immunology
  • Pathology

Background:

  • Heavy chain deposition (HCD) disease involves the abnormal production of immunoglobulin proteins.
  • Lymphoproliferative disorders associated with HCD exhibit diverse clinical and pathological features.
  • Understanding the cellular origin of HCD-producing cells is crucial for disease pathogenesis.

Purpose of the Study:

  • To review the structural and genetic diversity of HCD proteins.
  • To examine the clinicopathologic spectrum of HCD-related lymphoproliferative disorders.
  • To explore the potential common cellular precursor for HCD-producing cells.

Main Methods:

  • Literature review of studies on HCD protein abnormalities.
  • Analysis of clinicopathologic features in HCD-associated lymphoproliferative disorders.

Related Experiment Videos

  • Review of B cell biology, focusing on immunoglobulin gene somatic mutation.

    • Main Results:

    • HCD proteins display significant structural and genetic heterogeneity.
    • Associated lymphoproliferative disorders present with a wide range of clinical manifestations and pathological findings.
    • A common precursor cell, potentially a rare germinal center B cell, is proposed for HCD-producing cells.

    Conclusions:

    • The diversity in HCD protein abnormalities and disease features is substantial.
    • Despite heterogeneity, a unified cellular origin from a somatically mutating B cell precursor is plausible.
    • Further research into B cell development and mutation is warranted to fully elucidate HCD pathogenesis.